To The Moon

$IONQ Inc.(IONQ)$ just reported the strongest quarter in its history — and the market treated it like a rumor. On Thursday, November 5, the quantum computing company posted Q3 FY2026 revenue of $173.8 million, up 336% year over year, smashing the $141.49 million consensus estimate (FiscalAI data via Watch List News). Management raised full-year 2026 revenue guidance to $505–515 million from $450–460 million, remaining performance obligations more than doubled to $1.2 billion, and the company says its Superion 256 capacity for 2027 is sold out. None of that stopped the stock closing at $26.63 on November 5, just 6.9% above its 52-week low (24/7 Wall St). Friday brought a violent rethink: the stock traded up $5.69 to $32.12 by midday on 42.7 million shares against a 22.6 million average (The Markets Daily), the session gain printing at 23.19% on Distilla's tape.

So the question this piece answers: does a sold-out order book change what IonQ is — or just fund the next round of financing?

Figure 1 — The quarter at a glance: record revenue, a raised guide, a $1.2B order book, and a loss that roughly tripled. Sources: IonQ Q3 FY2026 results, 5 Nov 2026; Watch List News, 7 Nov 2026; 24/7 Wall St.

The Record Quarter Is Half a Foundry

Quantum computing names have been effectively un-investable on revenue for most of their public lives. The trade was always the science, not the sales. This quarter, that changed.

Of the $173.8 million in Q3 revenue, $90.3 million came from the IonQ Platform segment, up 127% year over year, and $83.5 million came from SkyWater, the onshore chip foundry IonQ acquired, contributing just two months of GAAP revenue (IonQ Q3 FY2026 results; Watch List News). Nearly half the record quarter is a semiconductor manufacturing business. The foundry is not just serving its new parent — SkyWater's quantum foundry revenue grew more than 30% year over year excluding IonQ, the D-Wave foundry agreement was extended, and a multi-year agreement with Qolab was signed (IonQ earnings call, 5 Nov 2026).

IonQ is now a vertically integrated manufacturer with a quantum computer attached, not the other way around. Management also disclosed that more than 40% of IonQ Platform revenue came from customers buying multiple products — repeat-purchase behavior research-stage companies rarely show (IonQ earnings call).

Figure 2 — Q3 FY26 revenue split: the Platform business and the SkyWater foundry are nearly equal halves. Sources: IonQ Q3 FY2026 results, 5 Nov 2026; Watch List News, 7 Nov 2026.

The Order Book Is Now the Story

The second structural change is the backlog. Combined remaining performance obligations more than doubled to $1.2 billion, including approximately $290 million in new IonQ Platform contracts signed in the quarter (Watch List News). Management stated on the call that all Superion 256 capacity for 2027 is sold out and order books are filling into 2028 (IonQ earnings call).

Third-party validation arrived the same week. IonQ advanced to Stage C of DARPA's Quantum Benchmarking Initiative — the only trapped-ion company to do so — a program with potential value of up to $300 million (IonQ earnings call). And $NVIDIA(NVDA)$ will deploy a Superion 256 system at its Accelerated Quantum Research Center, the first on-premise quantum deployment at that facility, connected to NVIDIA's AI supercomputing infrastructure (IonQ earnings call). Other Superion 256 partners include Florida International University, the University of Cambridge, Horizon Quantum, and SDT in South Korea.

Now the valuation, next to the order book. Rigetti ($Rigetti Computing(RGTI)$ ) trades at roughly 246x trailing sales and D-Wave ($QBTS) at roughly 276x, while IonQ's $1.2 billion backlog sits at about 22x guided FY2026 sales (24/7 Wall St). The market charges peers more than ten times IonQ's effective multiple for companies without a disclosed order book of this size.

Figure 3 — How the three quantum names are priced: IonQ measured on backlog-to-guided-sales, peers on trailing sales — the gap is the argument. Sources: 24/7 Wall St via Yahoo Finance, Nov 2026.

The Raise Was Real. So Was the Burn — and the Street Cut Targets Anyway

On paper, the guidance raise was clean: FY2026 revenue guidance moved to $505–515 million from $450–460 million, roughly a 12% lift at the midpoint (Watch List News). Adjusted EPS came in at -$0.29 against a -$0.35 estimate, IonQ's fourth consecutive beat (FiscalAI via Watch List News; 24/7 Wall St).

The counter-data is just as clean. Adjusted EBITDA loss widened to $133.6 million from roughly $49 million a year earlier (Watch List News; 24/7 Wall St), and GAAP operating expenses reached $606.9 million, which management attributed to acquisition integration and continued investment (Watch List News). Management expects Q4 adjusted EBITDA to improve and cited $3.7 billion in pro forma cash — but called profitability a longer-term goal (The Markets Daily). 24/7 Wall St also flags a potential $2 billion equity raise on the horizon; that figure is the outlet's assessment, not a company announcement.

The sell side split down the middle on Friday: Bank of America reaffirmed its buy with a $50 target while Needham cut its target from $65 to $48, both keeping buy ratings (The Markets Daily). MarketBeat's tally stands at 10 buys, 3 holds, 1 sell, with a $60.23 average target (The Markets Daily).

Figure 4 — FY2026 revenue guidance before and after the Q3 print, drawn at range midpoints. Sources: IonQ Q3 FY2026 results, 5 Nov 2026; Watch List News, 7 Nov 2026.

Bull Case and Bear Case

Bull case — each claim falsifiable:

1. Capacity is contracted, not hoped for: if 2027 Superion 256 units ship on the sold-out schedule, revenue visibility is contractual — checkable against 2027 delivery announcements.

2. DARPA Stage C is independent validation, in a program worth up to $300 million — checkable against DARPA disclosures.

3. The foundry adds revenue IonQ does not have to win on quantum merit: SkyWater foundry revenue grew 30%+ year over year ex-IonQ — falsifiable in the Q4 segment breakout.

4. The guide was raised off a base set only one quarter ago — if Q4 tracking holds, the raise was conservative, not promotional.

5. The NVIDIA AQR Center deployment anchors the hybrid GPU-QPU thesis — a second NVIDIA-side quantum deployment would confirm it.

Bear case — each claim falsifiable:

1. The burn nearly tripled: adjusted EBITDA went from roughly -$49 million to -$133.6 million in four quarters — if Q4 does not improve as guided, the trajectory argument breaks.

2. A possible ~$2 billion equity raise (24/7 Wall St's assessment) would dilute the very order book bulls are paying for — any filing confirms or kills this.

3. $1.2 billion of RPO against a ~$510 million FY26 guide implies most backlog converts well after 2026 — the conversion schedule has not been itemized.

4. Even after Friday's 23.19% session, the stock sits roughly 57% below its $73.65 52-week high on a week in which it fell as much as 16.68% (24/7 Wall St; Distilla) — Friday's 42.7 million share tape can reverse.

5. The quantum complex reprices together: when the AI-infrastructure tape sells off, contracted revenue or not, ~246x and ~276x peer multiples compress first.

Figure 5 — The counter-chart: adjusted EBITDA loss, Q3 FY25 vs Q3 FY26. The market sold the burn, not the beat. Sources: 24/7 Wall St via Yahoo Finance; IonQ Q3 FY2026 results.

Strategic Slam

Positioning, by ticker, in conditions rather than levels:

• $IONQ: the trade to own is backlog conversion, not the quantum headline. If the Q4 FY26 print (expected early 2027, date unconfirmed) shows the EBITDA loss narrowing from -$133.6 million while RPO keeps compounding, the ~22x multiple is defensible. If an equity raise lands first, expect compression regardless of revenue.

• $NVDA: the Superion 256 deployment is financially trivial but strategically useful — hybrid QPU-GPU clusters extend the accelerator ecosystem's moat. The confirm signal is a second NVIDIA-side quantum deployment.

• $RGTI and $QBTS: at ~246x and ~276x trailing sales without a comparable disclosed backlog, the risk is not the technology — it is being the last name repriced when the rotation favors contracted revenue.

Catalyst Calendar

• Nov 5, 2026 (done) — Q3 FY2026 results: revenue $173.8 million; guidance raised to $505–515 million.

• 2027 — Superion 256 deliveries against sold-out capacity; multiple Tempo systems planned for cloud capacity.

• Early 2027 (expected, unconfirmed) — Q4 FY2026 results: watch the EBITDA trajectory and any equity-raise filing.

• Ongoing — DARPA Stage C work: program value up to $300 million, milestone-gated.

Figure 6 — Catalyst timeline: from the Stage C ambition in February to a sold-out 2027 in nine months. Sources: IonQ Q3 FY2026 earnings call, 5 Nov 2026; Watch List News, 7 Nov 2026.

The Two-by-Two That Decides It

Everything above reduces to two uncertainties: whether the sold-out 2027 build ships on schedule, and whether demand holds into 2028. What each combination does to the thesis:

Figure 7 — Scenario matrix: execution on the sold-out 2027 build against the demand backdrop. Sources: IonQ Q3 FY2026 results; 24/7 Wall St via Yahoo Finance, Nov 2026.

Verdict

The order book makes IonQ the first quantum name you can underwrite like a manufacturer instead of a research lab — a $1.2 billion RPO, a sold-out 2027, and a foundry that supplies competitors. That is a genuinely new fact about this sector. But with the EBITDA loss at $133.6 million and a possible ~$2 billion raise per 24/7 Wall St, the equity is still a financing story wearing a revenue story's clothes. Cautiously constructive: the backlog is real, and the burn is its price. Position for conversion evidence, not for the headline.

Key Takeaways

1. Q3 FY26 revenue hit $173.8 million, up 336% year over year, beating the $141.49 million consensus; FY26 guidance was raised to $505–515 million.

2. Nearly half the record quarter — $83.5 million — came from the SkyWater foundry in only two months.

3. Remaining performance obligations more than doubled to $1.2 billion; 2027 Superion 256 capacity is sold out and 2028 order books are filling.

4. The cost: adjusted EBITDA loss of $133.6 million versus roughly $49 million a year ago, on $606.9 million of GAAP operating expenses.

5. The relative-value case is stark: IonQ's backlog at ~22x guided sales versus Rigetti at ~246x and D-Wave at ~276x trailing sales.

If 2027 is sold out but the money to build it is not raised yet — are you buying a backlog, or financing one?

Tickers: $IONQ $NVDA $RGTI $QBTS

Sources: IonQ Q3 FY2026 results and earnings call, 5 Nov 2026; Watch List News, 7 Nov 2026 (FiscalAI consensus data); The Markets Daily, 7 Nov 2026 (MarketBeat ratings data; BofA and Needham notes); 24/7 Wall St via Yahoo Finance, Nov 2026; Distilla Daily Market Brief, 7 Nov 2026.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or an offer to buy or sell any security. Figures are sourced as cited and may be revised by their original publishers. Past performance is not indicative of future results.